Anja S. Lindman’s former affiliation is Norwegian Institute of Public Health, Norway and Department of Biostatistics, Institute of Basic Medical Sciences, University of Oslo, Norway
The association between nonfasting triglycerides and cardiovascular disease (CVD) has recently been actualized. The aim of the present study was to investigate nonfasting triglycerides as a predictor of CVD mortality in men and women. A total of 86,261 participants in the Norwegian Counties Study 1974–2007, initially aged 20–50 years and free of CVD were included. We estimated hazard ratios (HRs) for deaths from CVD, ischemic heart disease (IHD), stroke and all causes by level of nonfasting triglycerides. Mean follow-up was 27.0 years. A total of 9,528 men died (3,620 from CVD, 2,408 IHD, 543 stroke), and totally 5,267 women died (1,296 CVD, 626 IHD, 360 stroke). After adjustment for CVD risk factors other than HDL-cholesterol, the HRs (95% CI) per 1 mmol/l increase in nonfasting triglycerides were 1.16 (1.13–1.20), 1.20 (1.14–1.27), 1.26 (1.19–1.34) and 1.09 (0.96–1.23) for all cause mortality, CVD, IHD, and stroke mortality in women. Corresponding figures in men were 1.03 (1.01–1.04), 1.03 (1.00–1.05), 1.03 (1.00–1.06) and 0.99 (0.92–1.07). In a subsample where HDL-cholesterol was measured (n = 40,144), the association between CVD mortality and triglycerides observed in women disappeared after adjustment for HDL-cholesterol. In a model including the Framingham CHD risk score the effect of triglycerides disappeared in both men and women. In conclusion, nonfasting triglycerides were associated with increased risk of CVD death for both women and men. Adjustment for major cardiovascular risk factors, however, attenuated the effect. Nonfasting triglycerides added no predictive information on CVD mortality beyond the Framingham CHD risk score in men and women.
Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2–14. PubMed
Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation. 1979;60:473–85. PubMed
Tverdal A, Foss OP, Leren P, Holme I, Lundlarsen PG, Bjartveit K. Serum triglycerides as an independent risk factor for death from coronary heart-disease in middle-aged Norwegian men. Am J Epidemiol. 1989;129:458–65. PubMed
The cardiovascular surveys in Finnmark, Sogn og Fjordane and Oppland. 1974–78, 1977–83 and 1985–88. http://www.fhi.no/dav/864a41442b.doc. Accessed 21 Dec 2009.
Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl. 1979;634:1–70. PubMed
Bjartveit K, Foss OP, Gjervig T. The cardiovascular disease study in Norwegian counties. Results from first screening. Acta Med Scand Suppl. 1983;675:1–184. PubMed
National Health Screening Service, Health Surveys of Finnmark, Sogn og Fjordane, and Oppland counties, Ullevål Hospital, Central laboratory, Oslo. The cardiovascular disease study in Norwegian counties. Results from second screening. Oslo: National Health Screening Service; 1988.
Stensvold I, Urdal P, Thürmer H, Tverdal A, Lund-Larsen PG, Foss OP. High-density-lipoprotein cholesterol and coronary, cardiovascular and all cause mortality among middle-aged Norwegian men and women. Eur Heart J. 1992;13:1155–63. PubMed
Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, Peto R. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341–53. PubMed
Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet. 2010;375:1634–9. CrossRef
Vollset SE, Selmer R, Tverdal A, Gjessing H. Mortality from smoking in Norway. Norwegian Institute of Public Health; 2006. (ISBN: 82-8082-163-5, electronic version).
- Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study
Anja S. Lindman
M. B. Veierød
J. I. Pedersen
- Springer Netherlands